These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3347344)

  • 1. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis.
    Andres PL; Finison LJ; Conlon T; Thibodeau LM; Munsat TL
    Neurology; 1988 Mar; 38(3):405-8. PubMed ID: 3347344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of neuromuscular deficit in ALS.
    Andres PL; Thibodeau LM; Finison LJ; Munsat TL
    Neurol Clin; 1987 Feb; 5(1):125-41. PubMed ID: 3550414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group.
    McGuire D; Garrison L; Armon C; Barohn R; Bryan W; Miller R; Parry G; Petajan J; Ross M
    Neurology; 1996 May; 46(5):1442-4. PubMed ID: 8628496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam.
    Shields RK; Ruhland JL; Ross MA; Saehler MM; Smith KB; Heffner ML
    Arch Phys Med Rehabil; 1998 Jul; 79(7):855-62. PubMed ID: 9685105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we eliminate placebo in ALS clinical trials?
    Bryan WW; Hoagland RJ; Murphy J; Armon C; Barohn RJ; Goodpasture JC; Miller RG; Parry GJ; Petajan JH; Ross MA; Stromatt SC;
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):11-5. PubMed ID: 12745612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative motor assessment in amyotrophic lateral sclerosis.
    Andres PL; Hedlund W; Finison L; Conlon T; Felmus M; Munsat TL
    Neurology; 1986 Jul; 36(7):937-41. PubMed ID: 3714055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of motoneuron loss in amyotrophic lateral sclerosis.
    Munsat TL; Andres PL; Finison L; Conlon T; Thibodeau L
    Neurology; 1988 Mar; 38(3):409-13. PubMed ID: 3347345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.
    Pascuzzi RM; Shefner J; Chappell AS; Bjerke JS; Tamura R; Chaudhry V; Clawson L; Haas L; Rothstein JD
    Amyotroph Lateral Scler; 2010 May; 11(3):266-71. PubMed ID: 19961264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.
    Pradas J; Finison L; Andres PL; Thornell B; Hollander D; Munsat TL
    Neurology; 1993 Apr; 43(4):751-5. PubMed ID: 8469335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing composite scores based on maximal voluntary isometric contraction and on semiquantitative manual motor testing in measuring limb strength in patients with ALS.
    Armon C; Ponraj E
    Neurology; 1996 Dec; 47(6):1586-7. PubMed ID: 8960753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls in the evaluation of isometric strength (TQNE) data in ALS.
    Conradi S; Ronnevi LO
    J Neurol Sci; 1996 Aug; 139 Suppl():60-3. PubMed ID: 8899660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group.
    McGuire D; Garrison L; Armon C; Barohn RJ; Bryan WW; Miller R; Parry GJ; Petajan JH; Ross MA
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S18-22. PubMed ID: 9419049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of verapamil in amyotrophic lateral sclerosis.
    Miller RG; Smith SA; Murphy JR; Brinkmann JR; Graves J; Mendoza M; Sands ML; Ringel SP
    Muscle Nerve; 1996 Apr; 19(4):511-5. PubMed ID: 8622731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
    Dupuis L; Loeffler JP
    Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
    Cappello V; Francolini M
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28972545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis.
    Ma D; Shuler JM; Kumar A; Stanford QR; Tungtur S; Nishimune H; Stanford JA
    Neurorehabil Neural Repair; 2017 Feb; 31(2):147-156. PubMed ID: 27573800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
    Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales.
    Guiloff RJ; Goonetilleke A
    Adv Neurol; 1995; 68():185-98. PubMed ID: 8787229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.